Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2023-10-01
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients
NCT06576154
Prophylactic Antibiotic Use in Hernioplasty
NCT00636831
Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair
NCT01273818
Antibiotic Prophylaxis in Mesh Repair of Inguinal Hernias
NCT01264003
Factors Related to Infection Prevention After Tension-free Inguinal Hernia Repair
NCT01802606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Antibiotic Group
Patients received a single intravenous dose of cefazolin (2 g) 30-60 min prior to skin incision.
Cefazolin
A single 2g intravenous dose administered once before surgery.
No Antibiotic Group
Patients did not receive antibiotic prophylaxis.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cefazolin
A single 2g intravenous dose administered once before surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Provided written informed consent.
Exclusion Criteria
* Laparoscopic repairs.
* Known immunosuppression, ongoing antibiotic therapy, or a known allergy to cefazolin.
* Refusal to participate.
17 Years
80 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Gumhori Teaching Hospital
UNKNOWN
Sana'a University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haitham Mohammed Jowah
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Waleed Mohammed Gilan, Asssociate Professor
Role: PRINCIPAL_INVESTIGATOR
Faculty of Medicine and Health Sciences, Sana'a University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Al-Gumhori Teaching Hospital
Sanaa, , Yemen
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU-Hernia-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.